Current as of: 2010
IN EFFECT// EFFECTIVE UNTIL DECEMBER 31, 2010 PER CHAPTERS 557 AND 558 OF 2008 // (a) The Program shall: (1) provide a prescription drug benefit subsidy, as determined by the Board, that may pay all or some of the deductibles, coinsurance payments, premiums, and copayments under the federal Medicare Part D Pharmaceutical Assistance Program for enrollees of the Program; and (2) provide the subsidy to the maximum number of individuals eligible for enrollment in the Program, subject to the moneys available in the segregated account under § 14–504 of this subtitle. (b) The Program may limit payment of any subsidy by paying the subsidy only on behalf of eligible individuals enrolled in a Medicare Part D Prescription Drug Plan or Medicare Advantage Plan that coordinates with the Program in accordance with federal requirements. (c) The Program: (1) may annually provide an additional subsidy, up to the full amount of the Medicare Part D Prescription Drug Plan premium, for individuals who qualify for a partial federal low–income subsidy; and (2) shall annually provide an additional subsidy up to the full amount of the Medicare Part D coverage gap, subject to the availability of: (i) funds provided under § 14–106.2 of this title; and (ii) any other funds available for this purpose. (d) The Program shall maintain a waiting list of individuals who meet the eligibility requirements for the Program but who are not served by the Program due to funding limitations. (e) The Board shall determine annually: (1) the number of individuals to be enrolled in the Program; (2) the amount of subsidy to be provided under subsections (a) and (c)(2) of this section; and (3) the amount of any additional subsidy provided under subsection (c)(1) of this section. (f) On or before January 1 of each year, the Board, in accordance with § 2–1246 of the State Government Article, shall report to the General Assembly on: (1) the number of individuals on the waiting list for the Program; and (2) to the extent that the Board is able to collect the information: (i) the number of enrollees with out–of–pocket prescription drug costs that exceed $2,250, broken down for each fiscal quarter; and (ii) the total annual out–of–pocket prescription drug costs for enrollees. Prev | Next________________________________________________________________________
Questions & Answers: InsuranceSee also: U.S. Code Provisions: InsuranceFederal Regulations: Insurance
 |
Email
Print